![UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter](https://pbs.twimg.com/media/EEB3-InVUAAP0wU.jpg)
UPCM 2022さんはTwitterを使っています: 「[Pharma Nugget] Hi, Class 2022! Here's your daily Knowledge Nugget™! #Pharmacology #PharmasMagetsNatin #SmarTherEveryday #BSEReady #ExamReady https://t.co/celU06XWMD」 / Twitter
Cellular Intrinsic Mechanism Affecting the Outcome of AML Treated with Ara-C in a Syngeneic Mouse Model | PLOS ONE
![Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fd63eb214ea90b377cbaa2b0d0bda2b9548b23ae/7-Figure3-1.png)
Bilateral Ear Swelling and Erythema after Chemotherapy: A Case Report of Ara -C Ears | Semantic Scholar
![X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/7a662cd6-4e37-40f6-9050-db057fcc2738/mol212146-fig-0006-m.jpg)
X‐linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery - Zhou - 2018 - Molecular Oncology - Wiley Online Library
![Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML](https://www.mdpi.com/cancers/cancers-13-00966/article_deploy/html/images/cancers-13-00966-g001.png)
Cancers | Free Full-Text | Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers | HTML
![Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/0d9a6ccd-b391-44ac-94b2-74651438f447/emmm201910419-abs-0001-m.jpg)
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy | EMBO Molecular Medicine
![Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1aea9d1a-3773-4672-951c-39a15e7752bd/ajh24246-fig-0001-m.jpg)
Acute myeloid leukemia—Major progress over four decades and glimpses into the future - Kantarjian - 2016 - American Journal of Hematology - Wiley Online Library
![GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-021-03504-2/MediaObjects/41419_2021_3504_Fig1_HTML.png)
GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia | Cell Death & Disease
![Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6cdbc294-34aa-472d-8f49-bf7904daaf0f/gr1a.jpg)
Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner - Experimental Hematology
![Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression](https://www.spandidos-publications.com/article_images/etm/14/2/etm-14-02-1081-g01.jpg)
Cytotoxic T lymphocytes promote cytarabine-induced acute myeloid leukemia cell apoptosis via inhibiting Bcl-2 expression
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition | Haematologica
![Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-018-0756-9/MediaObjects/13046_2018_756_Fig2_HTML.gif)